Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

Exclusion Criteria

• •Pregnant or nursing females
• •Polymicrobial bacteremia
• •Diagnosis of septic shock (refer to APPENDIX B)
• •Neutropenia (absolute neutrophil count \< 500/mm³)
• •Undergoing any type of dialysis or expected to start dialysis within 30 days
• •Moribund clinical condition with a high likelihood of death within 72 hours of randomization
• •Received an investigational drug within 30 days of study entry
• •Considered unlikely to comply with the study procedures or to return for scheduled post-treatment evaluations